Correlation Between PDS Biotechnology and Aptevo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Aptevo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Aptevo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Aptevo Therapeutics, you can compare the effects of market volatilities on PDS Biotechnology and Aptevo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Aptevo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Aptevo Therapeutics.

Diversification Opportunities for PDS Biotechnology and Aptevo Therapeutics

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between PDS and Aptevo is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Aptevo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptevo Therapeutics and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Aptevo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptevo Therapeutics has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Aptevo Therapeutics go up and down completely randomly.

Pair Corralation between PDS Biotechnology and Aptevo Therapeutics

Given the investment horizon of 90 days PDS Biotechnology Corp is expected to generate 0.4 times more return on investment than Aptevo Therapeutics. However, PDS Biotechnology Corp is 2.5 times less risky than Aptevo Therapeutics. It trades about -0.08 of its potential returns per unit of risk. Aptevo Therapeutics is currently generating about -0.06 per unit of risk. If you would invest  580.00  in PDS Biotechnology Corp on September 1, 2024 and sell it today you would lose (361.00) from holding PDS Biotechnology Corp or give up 62.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

PDS Biotechnology Corp  vs.  Aptevo Therapeutics

 Performance 
       Timeline  
PDS Biotechnology Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Aptevo Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Aptevo Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Aptevo Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

PDS Biotechnology and Aptevo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PDS Biotechnology and Aptevo Therapeutics

The main advantage of trading using opposite PDS Biotechnology and Aptevo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Aptevo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptevo Therapeutics will offset losses from the drop in Aptevo Therapeutics' long position.
The idea behind PDS Biotechnology Corp and Aptevo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities